{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pregabalin+300+mg", "query": { "intervention": "Pregabalin 300 mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 39, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pregabalin+300+mg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-05T14:57:36.652Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01057693", "title": "Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Neuropathy, Painful" ], "interventions": [ { "name": "pregabalin (Lyrica)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 633, "start_date": "2010-03-31", "completion_date": "2012-01-30", "has_results": true, "last_update_posted_date": "2021-01-20", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 150, "location_summary": "Birmingham, Alabama • Northport, Alabama • Gilbert, Arizona + 120 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Goodyear", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01057693" }, { "nct_id": "NCT00573261", "title": "A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetic Neuropathy" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2006-03", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2014-07-21", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00573261" }, { "nct_id": "NCT05488847", "title": "Opioid-Free Pain Protocol After Shoulder Arthroplasty", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Shoulder Arthropathy", "Shoulder Pain" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ropivicaine", "type": "DRUG" }, { "name": "Epinephrine", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Tizanidine", "type": "DRUG" }, { "name": "Magnesium", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxycodone Hydrochloride 5 Mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2022-06-25", "completion_date": "2026-09-01", "has_results": true, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05488847" }, { "nct_id": "NCT00954187", "title": "Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loma Linda University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 8, "start_date": "2009-11", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2017-01-09", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 1, "location_summary": "Loma Linda, California", "locations": [ { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00954187" }, { "nct_id": "NCT01747915", "title": "A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Tonic Clonic Seizures" ], "interventions": [ { "name": "Pregabalin Dose Level 1", "type": "DRUG" }, { "name": "Pregabalin Dose Level 2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "5 Years to 65 Years" }, "enrollment_count": 219, "start_date": "2013-04-03", "completion_date": "2019-02-20", "has_results": true, "last_update_posted_date": "2021-01-20", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 12, "location_summary": "Loxahatchee Groves, Florida • Orlando, Florida • Port Charlotte, Florida + 6 more", "locations": [ { "city": "Loxahatchee Groves", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Port Charlotte", "state": "Florida" }, { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT01747915" }, { "nct_id": "NCT04705480", "title": "Pregabalin vs. Gabapentin on Reducing Opioid Usage", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Analgesics", "Gabapentin", "Injuries", "Narcotics", "Pain", "Trauma" ], "interventions": [ { "name": "Pregabalin 50mg", "type": "DRUG" }, { "name": "Gabapentin 300mg", "type": "DRUG" }, { "name": "Neither Pregabalin nor Gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CAMC Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 109, "start_date": "2021-04-12", "completion_date": "2024-12-13", "has_results": true, "last_update_posted_date": "2026-01-06", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 1, "location_summary": "Charleston, West Virginia", "locations": [ { "city": "Charleston", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04705480" }, { "nct_id": "NCT01789216", "title": "Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Orthopaedic Fractures" ], "interventions": [ { "name": "NSAID", "type": "DRUG" }, { "name": "Gabapentinoids", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Major Extremity Trauma Research Consortium", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 450, "start_date": "2013-07", "completion_date": "2018-12-31", "has_results": false, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 17, "location_summary": "Miami, Florida • West Palm Beach, Florida • Indianapolis, Indiana + 13 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Shreveport", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01789216" }, { "nct_id": "NCT02725112", "title": "Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Pregabalin ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 25, "start_date": "2016-02-12", "completion_date": "2016-06-17", "has_results": false, "last_update_posted_date": "2021-01-20", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02725112" }, { "nct_id": "NCT01846182", "title": "Research Examining Gulf War Illness in Our Nations Service Members", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gulf War Illness" ], "interventions": [ { "name": "Duloxetine", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "44 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "44 Years to 70 Years" }, "enrollment_count": 112, "start_date": "2015-06-24", "completion_date": "2019-08-01", "has_results": true, "last_update_posted_date": "2021-03-12", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 2, "location_summary": "Temple, Texas • Waco, Texas", "locations": [ { "city": "Temple", "state": "Texas" }, { "city": "Waco", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01846182" }, { "nct_id": "NCT00883740", "title": "Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia", "Sleep Disorders" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2009-06", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2021-01-25", "last_synced_at": "2026-09-05T14:57:36.652Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Tucson, Arizona • San Diego, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00883740" } ] }